Clinical Trial Update: Study of Efficacy and Safety of LIB003 in Patient With CVD on Statins Requiring Additional LDL-C Reduction [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of LIB003 in patients with cardiovascular disease and high LDL-C on statins, seeking additional LDL-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Hyperlipidemia

Drugs mentioned

• LIB003

Snippet

Sponsor: LIB Therapeutics LLC | Conditions: Cardiovascular Diseases, Hyper-LDL-cholesterolemia | Phase 3 | Status: UNKNOWN